Plumas Bancorp (PLBC) director receives 4,200-share stock option grant

Rhea-AI Filing Summary

Plumas Bancorp director Michonne R. Ascuaga received an option grant for 4,200 shares of common stock. The Form 4 shows this as an acquisition of derivative securities coded as a grant or award. Following the grant, her reported holdings in this option total 4,200 derivative shares.

According to the footnote, these stock options will vest in four equal annual installments beginning on March 1, 2027, meaning the right to exercise the full award will be earned gradually over four years.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ascuaga Michonne R.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to buy common stock	4,200	$0.00	--

Holdings After Transaction: Option to buy common stock — 4,200 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ascuaga Michonne R.

(Last) (First) (Middle)

695 JUNIPER HILL ROAD

(Street)

RENO NV 89519

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLUMAS BANCORP [ PLBC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to buy common stock	$50.3	03/01/2026		A		4,200		(1)	03/01/2034	Common stock	4,200	$0	4,200	D

Explanation of Responses:

1. Stock options will vest in four equal annual installments beginning on March 1, 2027.

	/s/ Michonne R. Ascuaga	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PLBC director Michonne R. Ascuaga report on this Form 4?

Michonne R. Ascuaga reported receiving an option grant for 4,200 shares of Plumas Bancorp common stock. The transaction is coded as a grant or award acquisition of derivative securities, increasing her reported option holdings to 4,200 derivative shares following the grant.

How many Plumas Bancorp shares are covered by Michonne Ascuaga’s new stock option grant?

The new stock option grant covers 4,200 shares of Plumas Bancorp common stock. This entire amount is reported as derivative securities beneficially owned following the transaction, reflecting the full size of the award granted to the director in this filing.

When do Michonne Ascuaga’s Plumas Bancorp stock options begin vesting?

The stock options begin vesting on March 1, 2027. According to the footnote, they will vest in four equal annual installments starting on that date, so the vesting schedule extends over four years from the initial vesting date.

What is the vesting schedule for the 4,200-share Plumas Bancorp stock option grant?

The 4,200-share stock option grant vests in four equal annual installments. Vesting starts on March 1, 2027, meaning one-quarter of the options become exercisable each year over four years, subject to the terms of the award.

Is the reported Plumas Bancorp insider transaction a purchase or an award?

The reported transaction is an award, not an open-market purchase. The Form 4 codes it as a grant or other acquisition of derivative securities, reflecting compensation in the form of stock options rather than a cash-funded share purchase.